This site is intended for Healthcare Professionals only.

Concerns over HEE’s ‘no funding’ decision for IP training

Date:

Share post:

The Pharmacists’ Defence Association (PDA) has raised concern over the Health Education England (HEE)’s decision on cutting funding to independent prescribing training.

The HEE has reportedly decided that no funding will be available to back-fill trainees undertaking the pharmacist independent prescribing (PIP) qualification, or for the supervision of trainees by DPPs and DMPs.

The PDA noted that, whilst all successful trainee pharmacists will be entering the GPhC register as independent prescribers from 2026, the existing pharmacist workforce is reliant on opportunities to undertake prescriber training through release from their employment, and the ability to secure a Designated Medical Practitioner (DMP) or Designated Prescribing Practitioner (DPP) to support the 90 days of supervised practice required.

The association said it has already heard examples of potential DMPs or DPPs requesting a significant fee from trainees before they will provide supervision, adding that meeting that request is not an option for many.

“This latest decision threatens to undermine the availability of the large numbers of pharmacists seeing supervisors as more IP training becomes available,” it said in a statement.

The union also warned that this is also a cause for concern for the locum pharmacist workforce, where back-fill was never an option, and loss of earnings would be incurred if they wish to undertake PIP training.

“With such significant changes to pharmacists’ education, and the vision of the NHS for pharmacists to play a much greater role in providing clinical care to patients and the public, it is disappointing to see the lack of strategic planning and funding to support this programme through to see it reach its full potential,” Alison Jones, Director of Policy at the PDA, said.

“Rather than plan to overcome emerging barriers to the roll-out of the IP training, this approach makes it harder for the objectives of the initiative to be met. It could also be significantly unfair if the NHS subsequently makes a u-turn as any pharmacist who has self-funded a DPP/DMP for their training will rightly be frustrated if later cohorts do get funding.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

How pharmacists can help children and young people with asthma: 2024 AskAboutAsthma campaign highlights

The 2024 #AskAboutAsthma campaign calls on pharmacists to take an active role in improving asthma management and outcomes...

Huxley Europe relaunches HuxQ10 Capsules with triple certification

The relaunch underscores Huxley Europe's commitment to health and welfare, offering specially developed formulas for users with dietary...

Alastair Buxton outlines vision for Community Pharmacy at Westminster Health Forum

Alastair Buxton, Director of NHS Services at CPE, outlines critical issues and solutions at the Westminster Health Forum,...

Food prices remain UK consumers’ top concern, FSA report finds

Consumers worried about food affordability were more likely to take food safety risks to save money The Food...